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![hnRNPA1 is a critical mediator of the SK-induced ICD activity in mammary tumor cells\
**a.** and **b.** Western blot analyses of expression of HSP70 and HMGB1 in human (MDA-MB-231) and mouse (4T1) tumor cells. Some 4T1, 4T1-hnRNPA1, MDA-MB-231 and MB-231-hnRNPA1 cells were treated with SK or Dox at 5 μg/ml for 24 h. β-actin was used as a loading control.](oncotarget-09-32271-g004){#F4}
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